Smith & Nephew monopoly lost; FDA approves device from Britain
By Daniel Connolly July 18, 2007
The Birmingham Hip implant by British medical device maker Smith & Nephew was the first hip resurfacing product to go on sale in the United States and has helped drive revenue at the firm’s Memphis-based orthopedic units.
But a recent federal decision means the company will now face a rival in the fast-growing hip resurfacing market.
Earlier this month, the Food and Drug Administration approved the Cormet 2000 hip resurfacing device from British firm Corin Group PLC. An … Read the rest